Wilson Sonsini advised Investor Time BioVentures on the deal while WilmerHale represented Phantom Neuro. Phantom Neuro, the first-of-its-kind neurotech startup that delivers a low power, high...
Wilson Sonsini advised Investor Time BioVentures on the deal while WilmerHale represented Phantom Neuro. Phantom Neuro, the first-of-its-kind neurotech startup that delivers a low power, high...
You must be a Standard 1 Year member to access this content.